Andrew G. Renehan
#187,466
Most Influential Person Across History
Researcher
Andrew G. Renehan's AcademicInfluence.com Rankings
Andrew G. Renehancomputer-science Degrees
Computer Science
#7431
Historical Rank
Machine Learning
#2519
Historical Rank
Artificial Intelligence
#2817
Historical Rank
Database
#4280
Historical Rank
Download Badge
Computer Science
Andrew G. Renehan's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Andrew G. Renehan Influential?
(Suggest an Edit or Addition)Andrew G. Renehan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies (2008) (4540)
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis (2004) (1607)
- Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3 (1999) (981)
- Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials (2002) (649)
- Biological mechanisms linking obesity and cancer risk: new perspectives. (2010) (586)
- Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study (2018) (520)
- Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. (2016) (500)
- Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. (2015) (459)
- Obesity and cancer risk: the role of the insulin–IGF axis (2006) (449)
- Adiposity and cancer risk: new mechanistic insights from epidemiology (2015) (432)
- Stem cells: the intestinal stem cell as a paradigm. (2000) (329)
- The Obesity Paradox in Cancer: a Review (2016) (322)
- Growth hormone, the insulin-like growth factor axis, insulin and cancer risk (2011) (312)
- Surgeon-related factors and outcome in rectal cancer. (1999) (280)
- What is apoptosis, and why is it important? Education and debate (2001) (275)
- Obesity and cancer: pathophysiological and biological mechanisms. (2008) (264)
- Incident cancer burden attributable to excess body mass index in 30 European countries (2010) (247)
- Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis (2010) (233)
- Lifestyle factors and colorectal cancer risk (2): a systematic review and meta‐analysis of associations with leisure‐time physical activity (2009) (213)
- COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) (208)
- Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise (2003) (207)
- Obesity and cancer: An update of the global impact. (2016) (202)
- Lifestyle factors and colorectal cancer risk (1): systematic review and meta‐analysis of associations with body mass index (2009) (193)
- Clinico-pathological and treatment-related factors influencing survival in parotid cancer (1999) (150)
- Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis (2015) (149)
- Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer–Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial (2018) (144)
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. (2006) (141)
- Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas (1996) (139)
- Obesity and cancer: Pathophysiological and biological mechanisms (2008) (136)
- Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. (2011) (133)
- The prevalence and characteristics of colorectal neoplasia in acromegaly. (2000) (132)
- Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis (2003) (131)
- Preventing cancer, cardiovascular disease, and diabetes (2005) (126)
- Lymph node harvest in colon and rectal cancer: Current considerations. (2012) (123)
- Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer (2000) (113)
- Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications. (2003) (111)
- Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer (2004) (107)
- Colorectal cancer incidence trends in the United States and United kingdom: evidence of right- to left-sided biological gradients with implications for screening. (2010) (107)
- An analysis of the treatment of 114 patients with recurrent pleomorphic adenomas of the parotid gland. (1996) (107)
- Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults. (2016) (105)
- Dexamethasone versus standard treatment for postoperative nausea and vomiting in gastrointestinal surgery: randomised controlled trial (DREAMS Trial) (2017) (105)
- Acromegaly, growth hormone and cancer risk. (2008) (101)
- Framework to construct and interpret latent class trajectory modelling (2018) (100)
- Collider Bias Is Only a Partial Explanation for the Obesity Paradox (2016) (97)
- Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. (2018) (96)
- Interpreting the epidemiological evidence linking obesity and cancer: A framework for population-attributable risk estimations in Europe. (2010) (94)
- Body mass index at different adult ages, weight change, and colorectal cancer risk in the National Institutes of Health-AARP Cohort. (2012) (83)
- Circulating insulin-like growth factor II and colorectal adenomas. (2000) (79)
- Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. (2012) (76)
- Measuring the biological effect of presurgical metformin treatment in endometrial cancer (2016) (74)
- A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei (2008) (72)
- Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Multidisciplinary Management (2017) (71)
- High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis. (2015) (68)
- The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk (2018) (68)
- Linking diabetes and cancer: a consensus on complexity (2010) (67)
- Early cellular events in colorectal carcinogenesis (2002) (67)
- The relevance of apoptosis for cellular homeostasis and tumorigenesis in the intestine. (2001) (66)
- Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. (2020) (63)
- The Combination of Circulating Ang1 and Tie2 Levels Predicts Progression-Free Survival Advantage in Bevacizumab-Treated Patients with Ovarian Cancer (2014) (63)
- Lifestyle changes and reduction of colon cancer incidence in Europe: A scenario study of physical activity promotion and weight reduction. (2010) (61)
- Excess adiposity and survival in patients with colorectal cancer: a systematic review (2014) (60)
- Body mass index relates weight to height differently in women and older adults: serial cross-sectional surveys in England (1992–2011) (2016) (60)
- Bariatric surgery, weight reduction, and cancer prevention. (2009) (58)
- Slowing down of adult body mass index trend increases in England: a latent class analysis of cross-sectional surveys (1992–2010) (2014) (56)
- Meta-analysis in medical research: potentials and limitations. (2008) (56)
- International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer (2021) (55)
- Mechanisms of improved survival from intensive followup in colorectal cancer: a hypothesis (2005) (54)
- Comparison of Associations of Body Mass Index, Abdominal Adiposity, and Risk of Colorectal Cancer in a Large Prospective Cohort Study (2013) (53)
- Diabetes and cancer: 5 years into the recent controversy. (2014) (51)
- Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies (2016) (48)
- Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal Cancer. (2015) (47)
- Physical activity before and after diagnosis of colorectal cancer: disease risk, clinical outcomes, response pathways and biomarkers. (2007) (47)
- Association between Body Mass Index and Mortality for Colorectal Cancer Survivors: Overall and by Tumor Molecular Phenotype (2015) (45)
- The Development of an Umbrella Trial (PLATO) to Address Radiation Therapy Dose Questions in the Locoregional Management of Squamous Cell Carcinoma of the Anus (2016) (45)
- A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus. (2018) (43)
- Screening colonoscopy for acromegaly in perspective* (2001) (42)
- How to Manage the Obese Patient With Cancer. (2016) (42)
- IGF‐I, IGF binding protein‐3 and breast cancer risk: Comparison of 3 meta‐analyses (2005) (36)
- The Authors Respond. (2017) (36)
- Top ten research priorities for detecting cancer early. (2019) (35)
- A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei (2006) (35)
- Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study. (2017) (34)
- Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Anal Cancer (2017) (34)
- Insulin analogues and cancer risk: the emergence of second-generation studies (2011) (33)
- Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer (2012) (33)
- Determination of large bowel length and loop complexity in patients with acromegaly undergoing screening colonoscopy (2005) (33)
- Growth hormone receptor polymorphism and growth hormone therapy response in children: a Bayesian meta-analysis. (2012) (33)
- Risk-reducing laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasm: early outcomes and technique (2013) (32)
- Determination of IGF-I, IGF-II, IGFBP-2, and IGFBP-3 levels in serum and plasma: comparisons using the Bland-Altman method. (2003) (32)
- Controversies in the Management of Salivary Gland Disease (2013) (32)
- Childhood body mass index and height in relation to site-specific risks of colorectal cancers in adult life (2017) (31)
- Quantification of skeletal metastases in castrate‐resistant prostate cancer predicts progression‐free and overall survival (2014) (30)
- The effect of cigarette smoking use and cessation on serum insulin-like growth factors (2004) (30)
- A presurgical window-of-opportunity study of metformin in obesity-driven endometrial cancer (2015) (29)
- The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer (2016) (28)
- Acromegaly and colorectal cancer: risk assessment should be based on population-based studies. (2002) (27)
- Immunodetection and molecular forms of plasma vascular endothelial growth factor-C. (2003) (26)
- Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines (2015) (26)
- Diabetes, insulin therapy, and colorectal cancer (2005) (26)
- Physical Activity Before and After Diagnosis of Colorectal Cancer (2007) (25)
- Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma (2018) (25)
- Height and cancer: consistent links, but mechanisms unclear. (2011) (25)
- Obesity and Cancer Treatment Outcomes: Interpreting the Complex Evidence. (2020) (24)
- The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy. (2013) (23)
- Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab (2016) (23)
- Obesity as an Avoidable Cause of Cancer (Attributable Risks). (2016) (22)
- Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer (2017) (21)
- Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP Diet and Health Study. (2018) (21)
- Re: body mass index and risk of lung cancer among never, former, and current smokers. (2012) (20)
- Current treatment of anal squamous cell carcinoma. (2012) (20)
- Is “watch-and-wait” after chemoradiotherapy safe in patients with rectal cancer? (2018) (20)
- Obesity paradox and mortality in adults with and without incident type 2 diabetes: a matched population-level cohort study (2017) (19)
- Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy. (2014) (19)
- The Obesity Paradox and Mortality After Colorectal Cancer: A Causal Conundrum. (2016) (19)
- Colorectal neoplasia in acromegaly: the reported increased prevalence is overestimated (2000) (17)
- Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project (2020) (17)
- Tissue Stem cells: Biology and Applications (2006) (16)
- Excess Weight as a Risk Factor Common to Many Cancer Sites: Words of Caution when Interpreting Meta-analytic Evidence (2016) (16)
- Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC) (2018) (16)
- Cancer survivorship, excess body fatness and weight-loss intervention—where are we in 2020? (2020) (15)
- Statistics in practice. An illustrated guide to SPSS (1998) (15)
- The long road towards cancer prevention: 4 steps backward and 8 forward. (2010) (15)
- Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging (2017) (15)
- The Role of High Frequency Dynamic Threshold (HiDT) Serum Carcinoembryonic Antigen (CEA) Measurements in Colorectal Cancer Surveillance: A (Revisited) Hypothesis Paper (2011) (15)
- Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom) (2020) (15)
- Change in weight status from childhood to early adulthood and late adulthood risk of colon cancer in men: a population-based cohort study (2018) (15)
- A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues (2015) (15)
- Cancer survivorship, excess body fatness and weight-loss intervention—where are we in 2020? (2020) (15)
- Body Mass Index and Cancer Risk: The Evidence for Causal Association (2010) (14)
- Chronic Insulin Exposure does not Cause Insulin Resistance but is Associated with Chemo-resistance in Colon Cancer Cells (2013) (14)
- Body composition and outcome in patients undergoing resection of colorectal liver metastases (Br J Surg 2012; 99: 550–557) (2012) (14)
- Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms (2020) (14)
- Tissue Stem Cells (2006) (14)
- Obesity, insulin and chemoresistance in colon cancer. (2011) (13)
- Absence of excess body fatness (2019) (12)
- Guidelines for colonoscopic screening in acromegaly are inconsistent with those for other high risk groups (2003) (12)
- Long-term Quality of Life After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei: A Prospective Longitudinal Study (2018) (12)
- Paradoxical elevations in serum IGF‐II and IGF binding protein‐2 in acromegaly: insights into the regulation of these peptides (2001) (12)
- Development of MR quantified pancreatic fat deposition as a cancer risk biomarker. (2018) (11)
- Treatments and Outcomes of Peritoneal Surface Tumors Through a Centralized National Service (United Kingdom) (2009) (10)
- Techniques and Outcome of Surgery for Locally Advanced and Local Recurrent Rectal Cancer. (2016) (10)
- Early stage anal margin cancer: towards evidence‐based management (2019) (10)
- Prognostic relevance and performance characteristics of serum IGFBP‐2 and PAPP‐A in women with breast cancer: a long‐term Danish cohort study (2018) (10)
- Referral pathways and outcome of patients with colorectal peritoneal metastasis (CRPM). (2019) (9)
- Hormone, Growth Factors and Tumor Growth. (2008) (9)
- Acromegaly and colorectal cancer: Risk assessment should be based on population-based studies [4] (multiple letters) (2002) (9)
- Epidemiology of Overweight/Obesity and Cancer Risk (2011) (9)
- EPICURE: Ensemble Pretrained Models for Extracting Cancer Mutations from Literature (2021) (9)
- Re: Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. (2014) (8)
- RETRACTED ARTICLE: The ‘obesity paradox’ and survival after colorectal cancer: true or false? (2014) (8)
- Optimizing cancer care: specialization, coordination and cooperation (1999) (8)
- Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis (2015) (8)
- Increase in Serum Total IGF-I and Maintenance of Free IGF-I Following Intentional Weight Loss in Pre-menopausal Women at Increased Risk of Breast Cancer (2010) (8)
- Body fatness and bevacizumab-based therapy in metastatic colorectal cancer (2010) (8)
- Comment on Bordeleau et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366 (2014) (7)
- Re: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. (1999) (7)
- The development of composite circulating biomarker models for use in anticancer drug clinical development (2011) (7)
- The effects of sex steroid replacement therapy on an expanded panel of IGF-related peptides. (2007) (7)
- Obesity and cancer in Asia-Pacific populations. (2010) (7)
- Retraction Note to: The ‘obesity paradox’ and survival after colorectal cancer: true or false? (2015) (6)
- Watch-and-wait versus surgical resection for patients with rectal cancer - Authors' reply. (2016) (6)
- Utility of 18‐fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer (2012) (6)
- Prospective study of change in liver function and fat in patients with colorectal liver metastases undergoing preoperative chemotherapy: protocol for the CLiFF Study (2020) (6)
- Temporal improvements in loco-regional failure and survival in patients with anal cancer treated with chemo-radiotherapy: treatment cohort study (1990–2014) (2020) (6)
- Foreword: Implementing cancer prevention in Europe. (2010) (6)
- Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (L-CRS/HIPEC) for Perforated Low-Grade Appendiceal Mucinous Neoplasm (LAMN II) (2019) (6)
- Surveillance after colorectal cancer resection (2000) (6)
- Insulin and Cancer: Report of the Proceedings of the First International Workshop, October 27-28, 2007, Düsseldorf, Germany. (2008) (5)
- High-sensitivity HPV genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis (2015) (5)
- Cumulative incidence of metachronous colorectal cancer risk for mismatch repair gene mutation carriers is overestimated (2011) (5)
- Awareness of the link between obesity and cancer in UK school curricula (2019) (4)
- National Institute for Health and Clinical Excellence: The diagnosis and management of colorectal cancer: full guideline (2011) (4)
- Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme (2018) (4)
- Cancer and cardiovascular disease (2020) (4)
- The impact of excess body weight at the hospital frontline (2014) (4)
- Comment on: Morden et al. Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer: A Retrospective Cohort Study of Older Medicare Patients. Diabetes Care 2011;34:1965–1971 (2012) (4)
- Limitations of the National Cancer Data Base to Evaluate Early-Stage Anal Cancer Treatment Outcomes. (2018) (4)
- FDG PET‐CT imaging for pre operative staging in patients with colorectal cancer (2012) (4)
- No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels - An analysis within the COLOFOL randomized clinical trial. (2021) (4)
- Cancer prevention through weight control—where are we in 2020? (2020) (4)
- Cancer prevention through weight control—where are we in 2020? (2020) (4)
- Interaction between co-morbidities and cancer survival (2019) (4)
- Body-mass index and metastatic melanoma outcomes. (2018) (3)
- Watch-and-wait approach for rectal cancer: concepts of a subject-specific method. (2017) (3)
- Need to Distinguish the Term Sarcopenia From Risk Stratification Derived From Muscle Parameters. (2018) (3)
- c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial (2022) (3)
- Trigeminal neuralgia: a cautionary tale' (1994) (3)
- EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer (2021) (3)
- Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trial. (2019) (3)
- Linkage of the UK Clinical Practice Research Datalink with the national cancer registry (2018) (3)
- Anal cancer: different epidemiological and clinical definitions. (2017) (3)
- Circulating insulin-like growth factor 1 (IGF1) and mortality: meta-analysis and dose-response meta-regression (2011) (2)
- Retraction Note to: The ‘obesity paradox’ and survival after colorectal cancer: true or false? (2015) (2)
- Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer' (2016) (2)
- Patient and tumor characteristics impacting on lymph node metastases rate (LNMR) in squamous cell carcinoma of the anal canal and margin (SCCA) using data from the NCRI randomized phase III ACT II trial: Implications for radiotherapy target volume. (2014) (2)
- Factors predicting distant metastasis and subsequent management (2012) (2)
- IARC Hanbooks of Cancer Prevention: Absence of Excess Body Fatness (2018) (2)
- Re: Collider Bias Is Only a Partial Explanation for the Obesity Paradox Response (2017) (2)
- Gender differences in long‐term survival of patients with colorectal cancer (Br J Surg 2001; 88: 1092‐8) Letter 2 (2002) (2)
- Clinical and radiomics prediction of complete response in rectal cancer pre-chemoradiotherapy (2022) (2)
- Cancer risk and the growth hormone/IGF-I axis. (2004) (2)
- Body mass index and cancer mortality in patients with incident type 2 diabetes: A population‐based study of adults in England (2021) (2)
- 327 Obesity and overall cancer risk (2009) (2)
- Conditional survival of patients with rectal cancer undergoing Watch and Wait: The risk of recurrence over time. (2020) (2)
- Pre-specified pilot analysis of a randomised pilot/phase II/III trial comparing standard dose vs dose-escalated concurrent chemoradiotherapy (CRT) in anal cancer (PLATO-ACT5) (2019) (2)
- Pre-surgical window study of metformin in obesity-driven endometrial cancer (2015) (2)
- Cigarette smoking exposure, serum insulin-like growth factors, and cancer risk: A population-based study (2002) (1)
- Body mass index and cancer incidence (2011) (1)
- Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy. (2021) (1)
- Obesity and cancer (2010) (1)
- OR3,1 Exon 3 deletion polymorphism of the growth hormone receptor (GHR) and GH response: a report of 97 cases (Manchester) and literature meta-analysis (2008) (1)
- Latent class trajectory modelling: impact of changes in model specification. (2022) (1)
- EP-1277: Optimising RT dose for anal cancer - the development of three clinical trials in one platform (2017) (1)
- The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database (2022) (1)
- Core outcome research measures in anal cancer (2017) (1)
- Corrigendum to "Techniques and Outcome of Surgery for Locally Advanced and Local Recurrent Rectal Cancer" [Clinical Oncology 28 (2016) 103-115]. (2016) (1)
- Childhood Body Mass Index Trajectories, Adult-Onset Type 2 Diabetes and Obesity-Related Cancers. (2022) (1)
- Introducing PrefCoRe: Quantifying and implementing patient preferences for the treatment of high‐risk rectal cancer, including the new strategy of organ preservation (2020) (1)
- Establishing a colorectal cancer research database from routinely collected health data: the process and potential from a pilot study (2022) (1)
- Accuracy of multidetector computed tomography in identifying poor prognostic factors in colonic cancer (Br J Surg 2010; 97: 1407–1415) (2010) (1)
- in metastatic colorectal cancer Body fatness and bevacizumab-based therapy (2010) (1)
- PtdIns 3-kinase (2011) (1)
- Associations of specific-age and decade recall body mass index trajectories with obesity-related cancer (2021) (1)
- Insulin-Like Growth Factor–Binding Protein-3, Breast Cancer Risk, and Different Serum Assays11 The authors of the original article were invited to respond but did not do so. (2005) (1)
- A NOVEL TRIAL DESIGN FOR RECTAL CANCER: THE DREAMtherapy TRIAL (Dual REctal Angiogenesis MEK inhibition radioTherapy) (2011) (1)
- Gastrointestinal tumors, colorectal (2012) (1)
- Link Between Obesity and Early-Onset Colorectal Cancers (EOCRC): Importance of Accounting for BMI Trajectories in Early Life. (2022) (1)
- Obesity and cancer: links with survival differ from those with incidence. (2015) (1)
- CT-derived anthropometrics and post-operative outcomes in resections for pancreatic ductal adenocarcinoma: Skeletal muscle density influences post-operative length of stay (2014) (1)
- Epidemiology of Warthin's tumour of the parotid gland in an Asian population. (1999) (1)
- Watch-and-wait strategy in rectal cancer - Authors' reply. (2019) (1)
- Pancreas Cancer Molecular Targets for Therapy (2011) (1)
- Cytoreductive surgery and heated intraperitoneal chemotherapy with synchronous liver resection (2016) (1)
- Can we identify people with higher pancreatic cancer risk who present with type 2 diabetes (2017) (1)
- Weight Changes in Type 2 Diabetes and Cancer Risk: A Latent Class Trajectory Model Study (2021) (1)
- Delays in diagnosing oesophagogastric cancer. Misconceptions exist over whether delay in diagnosis influences survival. (1997) (1)
- Facial nerve damage following surgery for benign disease of the parotid gland—A retrospective study of 261 cases (2007) (1)
- Body mass index does not influence post-treatment survival in early stage endometrial cancer (2011) (1)
- Colorectal liver metastases: novel assessment tools for technical resectability (conor study) (2020) (1)
- The treatments and outcomes of peritoneal tumours through a centralised national service (2008) (1)
- Radiotherapy versus combined modality therapy for anal carcinoma (2004) (1)
- Metformin and Cancer (2012) (0)
- 138: Rectal cancer and fractionation sensitivity in the neoadjuvant radiation therapy setting: a project of metaanalysis and radiobiological modeling from individual patient data in randomized and observational data-sets (2014) (0)
- Severe polyneuropathy complicating active Crohn ’ s disease : rapid response to Infliximab (0)
- Excess body weight and GI/liver cancer risk (2012) (0)
- The Authors Respond. (2017) (0)
- Systematic Reviews & Meta-analyses What to Do With the Evidence? (2010) (0)
- Multicenter experience in extracapsular dissection of benign parotid neoplasms—1064 cases (2009) (0)
- British Medical Journal (1871) (0)
- Obesity and cancer: clinical epidemiology [in press]. (2012) (0)
- Obesity and cancer: clinical epidemiology (2014) (0)
- Chemotherapy dose reductions in obese patients undergoing adjuvant chemotherapy for colorectal cancer: secondary analyses of trial data and the Greater Manchester and Cheshire Cancer Network Audit. (2018) (0)
- FDG PET/CT for the pre-operative staging of metastatic colorectal cancer (2011) (0)
- Dietary intervention reduces intra-pancreatic fat (2016) (0)
- A selective policy in follow-up for bowel cancer (1998) (0)
- Multi centre experience of extracapsular dissection of benign parotid neoplasms (2007) (0)
- Jane Mathematical Modeling of Stem Cells : A Complexity Primer for the Stem-Cell Biologist (2014) (0)
- Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis (2015) (0)
- Abstract IA10: Angiopoietin/Tie2 as predictive biomarkers for bevacizumab in ovarian cancer (2015) (0)
- FDG PET-CT imaging for pre operative staging in patients with colorectal cancer (2020) (0)
- Associations of specific-age and decade recall body mass index trajectories with obesity-related cancer (2021) (0)
- Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: analysis of 1138 patients from the UK and Ireland Colorectal Peritoneal Metastases Registry (2022) (0)
- Diabetes and Cancer: Evidence for Risk, Methodology and Implications (2016) (0)
- Warthin's tumour: pathogenesis and current treatment options (2012) (0)
- P21 Colorectal cancer incidence trends in US and UK populations: a right- to left-sided biological gradient with implications for screening and chemoprevention (2010) (0)
- Insulin glargine and cancer: Concerns with reported study designs (2011) (0)
- O5: THE CLIFF AND CONOR STUDIES NOVEL ASSESSMENT TOOLS IN COLORECTAL LIVER METASTASES (CLIFF STUDY - CHANGE IN LIVER FUNCTION AND FAT IN PRE-OPERATIVE CHEMOTHERAPY FOR COLORECTAL LIVER METASTASES, CONOR STUDY (2021) (0)
- Do Systemic Antibiotics Prior to Cancer Diagnosis Impact on All-Cause Mortality for Malignant Cancers? Findings from Two UK Population-Based Cohort Studies (2019) (0)
- Insulin-like Growth Factor (IGF)-II Peptide Overexpression Early in the Adenoma-Carcinoma Sequence. (2001) (0)
- SP-0104: DREAMtherapy trial of novel rectal chemoradiotherapy (2014) (0)
- O-4 Average cumulative relative dose of adjuvant chemotherapy is more important than average relative dose intensity for colorectal cancer survival, with implications for treating obese patients: The OCTOPUS consortium (2021) (0)
- FDG PET/CT as an add-on imaging test versus routinely used imaging modalities for pre-operative staging in patients with primary, recurrent or metastatic colorectal cancer: a handsearch study (2011) (0)
- FDG PET/CT in the pre-operative staging of recurrent colorectal cancer (2011) (0)
- Population Candidate Gene Association Study (2011) (0)
- European Association for the Study of Diabetes Annual Conference Explores Links Between Diabetes and Cancer (2011) (0)
- Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom) (2020) (0)
- What are the links between diabetes and cancer (2011) (0)
- Three-dimensional (3D) magnetic resonance volume assessment and loco-regional failure in anal cancer: early evaluation case-control study (2020) (0)
- Stem cells and cancer. (2008) (0)
- OR2,4 The development of multi-dimensional models of serum IGF-I, -II, IGFBP-2 and -3 using artificial neural networks as “composite biomarkers” to predict colorectal cancer (2008) (0)
- The early detection of cancers in patients with type 2 diabetes: the importance of understanding the detection time bias. (2015) (0)
- Cancer surveillance, obesity, and potential bias. (2019) (0)
- FDG PET/CT economics, decision-making and quality of life search strategies (2011) (0)
- Re: Sternomastoid flap after superficial parotidectomy. (2003) (0)
- Research Highlights (2004) (0)
- The PanORAMA project: Pancreatic cancer predisposition, obesity-related deposition assessment using magnetic resonance imaging (2016) (0)
- Quality assessment operational definitions (2011) (0)
- The management of low grade appendiceal mucinous neoplasms (2008) (0)
- Obesity & Cancer (Epidemiology) (2012) (0)
- Role of obesity in the incidence and progression of surgical cancers [Hunterian lecture] (2012) (0)
- P-08 IGF-I, IGFBP-3 and cancer risk: poor performance on discrimination analysis as an explanation of inconsistencies between risk-association studies (2008) (0)
- OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL). (2017) (0)
- Outcomes in Patients with Colorectal Peritoneal Carcinomatosis Treated in a National Treatment Centre: Beyond the Palliative Pathway (2011) (0)
- Epidemiological evidence linking obesity and cancer risk (2011) (0)
- Abstract 3034: Excess weight by degree and duration and cancer risk: an individual participant data (IPD) meta - analyses of over 1.4 million participants (ABACus2 consortium) (2023) (0)
- Measuring patient preferences for the treatment of rectal cancer (2020) (0)
- First results from the phase I dual rectal angiogenesis MEK inhibition radiotherapy (DREAMtherapy) trial in locally advanced rectal cancer. (2012) (0)
- SURGICAL OUTCOMES IN OLDER PATIENTS WITH PERITONEAL MALIGNANCY TREATED WITH CYTOREDUCTIVE SURGERY AND HIPEC: EXPERIENCE THE UK AND IRELAND COLORECTAL PERITONEAL METASTASES STUDY GROUP (2022) (0)
- Primary Cancer Site (2011) (0)
- A common polymorphism of the growth hormone receptor (GHR) and response to GH: a report of 97 cases (Manchester) and literature meta-analysis (2008) (0)
- ONCOLOGICAL OUTCOME AFTER SALVAGE TREATMENT FOR LOCAL RE-GROWTH FOLLOWING "WATCH AND WAIT" FOR CLINICAL COMPLETE RESPONSE IN PATIENTS WITH RECTAL CANCER. (2017) (0)
- Chapter 2 Epidemiology of Overweight / Obesity and Cancer Risk (2011) (0)
- SP6.1.2 Colorectal Liver Metastases - Novel Assessment Tools for Resectability (The CoNoR Study): Results from an International Questionnaire of Hepatopancreatobiliary Surgeons (2021) (0)
- TABLE 22, Primary rectal cancer – cost per QALY gain (2011) (0)
- IGF-I; IGF-binding protein-3 and breast cancer risk (2005) (0)
- The Role of Human Papilloma Virus (in anal cancer aetiology and prevention) (2011) (0)
- Natural history and treatment of recurrent carcinomas of the parotid gland (1997) (0)
- Temporal improvements in loco-regional failure and survival in patients with anal cancer treated with chemo-radiotherapy: treatment cohort study (1990–2014) (2020) (0)
- Evaluation of Cancer Screening (2000) (0)
- Sugarbaker procedure for pseudomyxoma peritonei (2006) (0)
- Insulin, IGF-1, diabetes and the potential for tumour progression (2010) (0)
- Trajectories of weight change from late adolescence to late middle age for lean and obese individuals (2010) (0)
- The impact of type 2 diabetes on survival in patients with cancer independent of its effect on survival in individuals without cancer: a matched cohort analysis (2019) (0)
- Included and excluded studies identified by the search strategy (2011) (0)
- 165 INVITED Body Mass Index and Cancer Incidence (2011) (0)
- Incomplete adaptive response and chemoresistance to chronic insulin exposure in colon cancer cells [submitted] (2012) (0)
- Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD). (2023) (0)
- Risk Factors for Cancer Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP Diet and Health Study (2019) (0)
- P-87 IGF-I:IGFBP-3 molar ratio and disease risk: statistical considerations and level of agreement with free IGF-I (2008) (0)
- Epidemiological Evidence for a Link Between Diabetes & Cancer (2012) (0)
- Abstract LB-276: Prospective study of body mass index and adult weight change with colorectal cancer survival, overall and by tumor microsatellite instability status (2014) (0)
- Exercise, obesity and the risk of breast cancer (2004) (0)
- TP9.2.21Laparoscopy in Emergency General Surgery (The LEGS Study): NELA Database Analysis -Comparison of Outcomes in Laparoscopic versus Open Surgery (2021) (0)
- Liver tumours and obesity (2012) (0)
- Protocol for the CoNoR Study: A prospective multi-step study of the potential added benefit of two novel assessment tools in colorectal liver metastases technical resectability decision-making (2023) (0)
- Rectal cancer - Complete Response Register (2012) (0)
- Diet, lifestyle and colorectal cancer risk: a lot has changed since Burkitt (2010) (0)
- Response to 'Can collider bias fully explain the obesity paradox?' (2017) (0)
- IGF-1, IGFBP-3, and cancer risk (2004) (0)
- ADDED VALUE IN DISCRIMINATION PERFORMANCE OF TUMOUR PARAMETERS AND NOVEL FEATURES DETERMINED USING ROUTINE PRE-TREATMENT MRI IN PATIENTS WITH ANAL CANCER. (2017) (0)
- The Keswick to Barrow Walkers ’ Challenge By (0)
- Treatment of recurrent pleomorphic adenomas of the parotid gland: multinodular versus solitary tumours (1996) (0)
- Systematic review protocol: FDG PET-CT imaging for pre-operative staging in patients with primary colorectal cancer (2011) (0)
- The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without pre-operative chemotherapy [in revision] (2012) (0)
- High resection rates of colorectal liver metastases after standardized follow-up and multimodal management: an outcome study within the COLOFOL trial. (2023) (0)
- British Medical Journal (1913) (0)
- Bias in the estimation of adult body mass index from general practice records (2014) (0)
- P2.05-058 Blood Biomarkers of Inflammation, Tumor Burden and Proliferation Predict Radiotherapy Response and Toxicity in Lung Cancer: Topic: Toxicities (2017) (0)
- Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer—Letter (2017) (0)
- A Novel Automated Approach to Mutation-Cancer Relation Extraction by Incorporating Heterogeneous Knowledge (2022) (0)
- for colorectal cancer conventional follow up after curative resection Cost effectiveness analysis of intensive versus (2005) (0)
- The relationship between adult body mass index and height in England (1991-2009) (2015) (0)
- OC-0507: The effect of incidental dose on out-of-field failure probability in anal cancer (2018) (0)
- Edinburgh Research Explorer Body mass index relates weight to height differently in women and older adults (2018) (0)
- FDG PET/CT for the pre-operative staging of primary colorectal cancer (2011) (0)
- BJS Prize Session (2020) (0)
- S33. The development of a Cancer Prevention Research Network (North West of England) (2008) (0)
- Abdominal Adiposity, Hormonal Replacement Therapy and Risk of Colon and Rectal Cancer in the NIH-AARP Cohort [submitted] (2012) (0)
- Obesity and dietary approaches to cancer prevention (2018) (0)
- Affordability as a positive concept : Analysing how households meet the costs of care across communities and between conditions (2012) (0)
- The therapeutic impact of FDG PET/CT in the pre-operative staging of colorectal cancer (2011) (0)
- The development of a novel tool for rectal cancer patients in the watch-and-wait program: An international Delphi exercise (2023) (0)
- RETRACTED ARTICLE: The ‘obesity paradox’ and survival after colorectal cancer: true or false? (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Andrew G. Renehan?
Andrew G. Renehan is affiliated with the following schools:
